Immunization Roundup: Updated COVID-19 Vaccines, Mpox Approval, and More
Drug Topics
SEPTEMBER 2, 2024
Catch up on important immunization news from the month of August.
Mon.Sep 02, 2024
186 
CDC Recommends Preventative Action Amid Rising Cases of West Nile Virus
Pharmacy Times
SEPTEMBER 2, 2024
Cases have been detected in 33 US states so far this year, and the virus has recently hospitalized the former Chief Medical Advisor to the President of the US Anthony Fauci.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
STAT+: At major cardiology conference, Wegovy’s the word
STAT
SEPTEMBER 2, 2024
LONDON — When Europe’s largest cardiology conference opened here this past Friday, one of the first sessions centered entirely on a single drug. It cut the risk of complications from a common form of heart failure, researchers reported. It helped improve the structure of the heart as well as its function. It even saved the lives of people with Covid-19 — a respiratory infection of all things.
As mpox cases rise over 18,000, UNICEF tenders for vaccines
pharmaphorum
SEPTEMBER 2, 2024
UNICEF has issued an emergency tender to secure mpox vaccines for countries dealing with the brunt of the current outbreak
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Aptose Biosciences secures funds for AML treatment development
Pharmaceutical Technology
SEPTEMBER 2, 2024
Aptose Biosciences has secured a loan of $10m through a facility agreement with Hanmi Pharmaceutical to develop tuspetinib.
Two of three trials fail, but Sanofi will still file MS drug
pharmaphorum
SEPTEMBER 2, 2024
Sanofi eyes filings for multiple sclerosis therapy tolebrutinib, although two of three phase 3 trials miss their primary endpoints
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Novavax wins FDA emergency approval for updated Covid-19 vaccine
Pharmaceutical Technology
SEPTEMBER 2, 2024
The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the past two weeks.
iRhythm wearable heart monitor raises AFib diagnoses by 52%
pharmaphorum
SEPTEMBER 2, 2024
iRhythm's Zio XT wearable heart monitor raises AFib diagnoses by 52%, but doesn't reduce stroke hospitalisations in GUARD-AF trial.
ESC 2024: GLP-1RAs show lower CV risk in 32,883-strong meta-analysis
Pharmaceutical Technology
SEPTEMBER 2, 2024
GLP-1RAs’ reduce CV risk, including reducing all-cause mortality and risk of MI, promoting weight loss and enhancing blood pressure control.
Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path Ahead
Pharmacy Times
SEPTEMBER 2, 2024
High-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Rules? Where We’re Going, We Don’t Need Rules: FDA Goes Back to the Future With Recent Hatch-Waxman Policy Shifts; What’s a Company to do?
The FDA Law Blog
SEPTEMBER 2, 2024
COVID-19 Vaccines Targeting New Variants for 2024-2025 Season
Pharmacy Times
SEPTEMBER 2, 2024
Robert Walker discusses the updated COVID-19 vaccines targeting the new JN.1 lineage of the virus and the challenges of addressing vaccine hesitancy to protect individuals and communities.
Nxera wins $35m after Phase II schizophrenia trial success
Pharmaceutical Technology
SEPTEMBER 2, 2024
Nxera will receive $35m from Neurocrine triggered by the successful completion of the Phase II trial of NBI-568 in schizophrenia.
Innovative hypertension polypill study achieves “significant” outcomes
European Pharmaceutical Review
SEPTEMBER 2, 2024
Three anti-hypertensive drugs combined in low doses into a single pill has been shown to be superior to standard care for lowering blood pressure in patients with uncontrolled hypertension. The oral treatment GMRx2 is biopharma George Medicines’ lead drug candidate. The once-daily, three-in-one pill contains telmisartan, amlodipine and indapamide at a quarter, half or standard doses.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PHC uses LiCellGrow prototype for cell and gene therapy manufacture
Pharmaceutical Technology
SEPTEMBER 2, 2024
PHC Corporation has introduced a prototype of LiCellGrow, a cell expansion system designed to manufacture cell and gene therapy products.
BIA sends message to UK chancellor on R&D tax credits
pharmaphorum
SEPTEMBER 2, 2024
Biotech industry body BIA calls for new UK Chancellor Rachel Reeves to take sector-specific approach to R&D tax credits to tackle widespread fraud and abuse of the system.
Keeping Audit and Inspection Programs Current
BioPharm
SEPTEMBER 2, 2024
Updating your audits and inspections program ensures inspection preparedness, says Siegfried Schmitt, vice president, Technical at Parexel.
The value of CNS-specific eCOA provider in clinical trials
Pharmaceutical Technology
SEPTEMBER 2, 2024
The pharmaceutical industry is continuously evolving, driven by the imperative to develop more effective and personalized treatments.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Personify Health Offers Employers GLP-1s Best Practices for Coverage Options
PharmExec
SEPTEMBER 2, 2024
The insurance company is offering the guidance in response to continued popularity of the drugs which are commonly used for weight-loss management.
ESC 2024: Emerging data on novel therapeutic strategies for targeting lipids
Pharmaceutical Technology
SEPTEMBER 2, 2024
New insights on the PACMAN-AMI trial for patients with acute myocardial infarction are presented at the ESC Congress, among other updates.
Cardinal Health Introduces New Tennessee Advanced Therapy Innovation Center
Pharmaceutical Commerce
SEPTEMBER 2, 2024
The 8,000 square-foot facility—located within the wholesaler’s Le Vergne distribution center— is expected to help tackle cell and gene therapy logistical challenges.
ESC 2024: Single-pill hypertension combo delivers positive results
Pharmaceutical Technology
SEPTEMBER 2, 2024
A single-pill combination could present a better option for hypertension patients, said researchers at the ESC congress.
Radiotherapies: Q&A with Thijs Spoor
PharmExec
SEPTEMBER 2, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Johnson & Johnson picks Onco360 as pharmacy partner for LAZCLUZE
Pharmaceutical Technology
SEPTEMBER 2, 2024
Johnson & Johnson has selected Onco360 as a pharmacy partner for the distribution of LAZCLUZE (lazertinib).
In conversation with consultant pharmacist in critical care Reena Mehta
Hospital Pharmacy Europe
SEPTEMBER 2, 2024
Reena Mehta, a consultant pharmacist in critical care at King’s College Hospital, London, UK, has become the first pharmacist appointed as chair of the Intensive Care Society’s Learning division. She talks to Katherine Price about bringing a different perspective to the role, ensuring diverse and multidisciplinary education opportunities for the critical care community in order to deliver the highest quality of care to the sickest of patients in hospitals.
Jacobio Pharma grants Allist rights to two assets in China
Pharmaceutical Technology
SEPTEMBER 2, 2024
Jacobio Pharma has out-licensed the China rights of its assets, glecirasib and JAB-3312, to Shanghai Allist Pharmaceuticals.
Episode 584: Remind me, do medications that target brain amyloid improve my dementia?
Therapeutics Education Collaboration
SEPTEMBER 2, 2024
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you all the numbers so you will be able to properly discuss these medications with your patients.
Let's personalize your content